Withus Pharmaceutical. Co., LTD
330350 | KO
Overview
Corporate Details
- ISIN(s):
- KR7330350000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 동산로12길 9, 서초구
- Website:
- https://withuspharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 942.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 918.9 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 22.9 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.0 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 404.2 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 124.2 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.2 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.6 KB | ||
| 2025-02-12 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.9 KB | ||
| 2024-12-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-20 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-11-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 74.4 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 840.0 KB | ||
| 2024-09-19 00:00 |
Regulatory Filings
생산중단
|
Korean | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Withus Pharmaceutical. Co., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Withus Pharmaceutical. Co., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Withus Pharmaceutical. Co., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
%20Inc./other/Mind_Medicine_MindMed_Inc.-logo.png){kind=logo}
Developing psychedelic-inspired medicines and novel therapies for brain health disorders.
United States of America
MNMD
United States of America
MNMD
Developing targeted treatments for hypertension & CKD driven by elevated aldosterone.
United States of America
MLYS
United States of America
MLYS
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
United States of America
NERV
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
United States of America
INKT
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America
MIRA
United States of America
MIRA
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America
MIRM
United States of America
MIRM
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium
MITRA
Belgium
MITRA
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan
4595
Japan
4595
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea
142760
South Korea
142760
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden
MOB
Sweden
MOB